Citrate targets FBPase and constitutes an emerging novel approach for cancer therapy

Gao-Min Liu and Yao-Ming Zhang recently published a review entitled «Targeting FBPase is an emerging novel approach for cancer therapy» (Liu and Zhang in Cancer Cell Int 18:36, 2018). In this paper, the authors highlighted how the down regulation or inactivation of FBPase, a rate limiting enzyme of...

Descripción completa

Detalles Bibliográficos
Autores principales: Icard, Philippe, Fournel, Ludovic, Coquerel, Antoine, Gligorov, Joseph, Alifano, Marco, Lincet, Hubert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6225682/
https://www.ncbi.nlm.nih.gov/pubmed/30455595
http://dx.doi.org/10.1186/s12935-018-0676-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6225682/
https://www.ncbi.nlm.nih.gov/pubmed/30455595
http://dx.doi.org/10.1186/s12935-018-0676-y

Ejemplares similares